131117-57-2

Usage

Uses

Used in Pharmaceutical Industry:
Boussingoside A1 is used as a potential therapeutic agent for the treatment of inflammatory diseases due to its anti-inflammatory properties. It can help alleviate symptoms and reduce the severity of inflammation in various conditions.
Boussingoside A1 is also used as a potential therapeutic agent for the treatment of viral diseases, as it has been found to possess anti-viral properties. It can potentially inhibit the replication and spread of viruses, providing a natural alternative to conventional antiviral medications.
Used in Antioxidant Applications:
Boussingoside A1 is used as an antioxidant to combat oxidative stress and protect cells from damage caused by reactive oxygen species. Its antioxidant properties can be beneficial in the prevention and treatment of various oxidative stress-related conditions, such as neurodegenerative diseases and cardiovascular disorders.
Used in Nitric Oxide Production Inhibition:
Boussingoside A1 is used as an inhibitor of nitric oxide production, which can help regulate the immune response and reduce inflammation. By inhibiting nitric oxide production, Boussingoside A1 may have potential applications in the treatment of conditions associated with excessive nitric oxide levels, such as septic shock and inflammatory bowel disease.

Downstream Products

• 94414-09-2 3β-hydroxy-30-norolean-12,19-dien-28-oic acid 
• 53526-69-5 Larreagenin A 
• 94414-12-7 (4aR,6aS,6bR,8aR,10S,12aR,12bR,14bS)-2,10-Dihydroxy-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid methyl ester 
• 94414-08-1 (4aR,6aS,6bR,8aR,10S,12aR,12bR,14bS)-2,10-Dihydroxy-2,6a,6b,9,9,12a-hexamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid